XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net income (loss) $ (6,992,927) $ (4,911,374)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 193,139 162,670
Share-based compensation 287,455 456,001
Amortization of deferred issuance costs 471,387 497,656
Changes in fair value of warrants and derivative (335,033) (646,319)
Non-cash interest related to bridge funding 58,002 98,685
Warrants issued as non- cash finance charge 0 72,862
Loss on exchange of debt 1,073,317 (0)
Loss on extinguishment of debt 111,928 0
Non-cash expenses related to equity line agreement 425,367 0
Change in assets and liabilities    
Accounts receivable 7,271 (1,491)
Prepaids and other current assets (287,663) (38,539)
Accounts payable (156,403) 220,633
Accrued and other liabilities (127,449) 448,459
Accrued interest on promissory and convertible notes 0 (6,190)
Net cash (used in) operations (5,271,609) (3,646,947)
Investing Activities    
Fixed assets (5,115) 0
Intangible assets - Patents (316,822) (119,522)
Net cash (used in) investing activities (321,937) (119,522)
Financing Activities    
Bridge funding cash issuance costs 0 (323,301)
Equity line cash issuance costs (367,865) (74,916)
Preferred stock cash issuance costs (90,000) 0
Common stock cash issuance costs (788,099)  
Proceeds from equity line 1,754,032 1,462,949
Proceeds from issuance of promissory notes 0 2,250,000
Proceeds from sale of preferred stock 1,000,000 1,000
Redemption of preferred stock 0 (1,000)
Proceeds from sale of common stock and warrants, Reg A+ 529,254 0
Proceeds from sale of common stock and warrants, ATM 288,294  
Repayment of promissory notes (300,973) 0
Proceeds from sale of common stock and warrants related to public offering 3,001,495 0
Net cash provided by financing activities 5,026,138 3,314,732
Net increase (decrease) in cash and cash equivalents (567,408) (451,737)
Cash, cash equivalents, and restricted cash, beginning of period 1,031,069 1,482,806
Cash, cash equivalents, and restricted cash, end of period 463,661 1,031,069
Cash paid for interest 13,072 10,705
Cash paid for income taxes 0 0
Non- cash activities    
Issuance of warrants related to bridge funding 0 67,500
Original issuance discount (15%) related to bridge funding 0 344,118
Liability to issue common shares 0 33,297
Issuance of commitment shares related to bridge funding 0 175,619
Fair value of warrants and derivative related to first tranche bridge funding 0 742,988
Fair value of warrants and derivative related to second tranche bridge funding 0 153,810
Fair value of warrants and derivative related to third tranche bridge funding 0 160,012
Dividends accrued on preferred shares 59,675 0
Exchange of indebtedness for common shares 1,771,606 0
Exchange of indebtedness for preferred shares 930,052 0
Conversion of preferred stock to common stock 129,999 0
Issuance of common shares related to restricted stock units 216,597 0
Issuance of commitment shares related to bridge funding $ 33,297 $ 0